We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Profound Medical Corp | TSX:PRN | Toronto | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.07 | -0.69% | 10.01 | 10.01 | 10.24 | 10.20 | 10.01 | 10.08 | 1,200 | 21:00:00 |
TORONTO, Oct. 31, 2019 /CNW/ - Arun Menawat, Chief Executive Officer, Profound Medical Corp. (PRN), joined Dani Lipkin, Innovation Sector Head, Capital Formation, Toronto Stock Exchange and TSX Venture Exchange, to open the market. Profound Medical develops customizable, incision-free therapies, which combine real-time Magnetic Resonance (MR) imaging, thermal ultrasound and closed-loop temperature feedback control for the radiation-free ablation of diseased tissue. Profound Medical Corp. graduated and commenced trading on Toronto Stock Exchange on July 13, 2018.
SOURCE TMX Group Limited
Copyright 2019 Canada NewsWire
1 Year Profound Medical Chart |
1 Month Profound Medical Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions